201 related articles for article (PubMed ID: 32376108)
1. Archetype analysis of older adult immunization decision-making and implementation in 34 countries.
Privor-Dumm L; Vasudevan P; Kobayashi K; Gupta J
Vaccine; 2020 May; 38(26):4170-4182. PubMed ID: 32376108
[TBL] [Abstract][Full Text] [Related]
2. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
[TBL] [Abstract][Full Text] [Related]
3. Closing the pneumococcal conjugate vaccine (PCV) introduction gap: an archetype analysis of last-mile countries.
Banerjee P; Huber J; Denti V; Sauer M; Weeks R; Dhaliwal BK; Shet A
Glob Health Action; 2023 Dec; 16(1):2281065. PubMed ID: 38084434
[TBL] [Abstract][Full Text] [Related]
4. Challenges in adult vaccination.
de Gomensoro E; Del Giudice G; Doherty TM
Ann Med; 2018 May; 50(3):181-192. PubMed ID: 29338438
[TBL] [Abstract][Full Text] [Related]
5. Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries.
Sauer M; Vasudevan P; Meghani A; Luthra K; Garcia C; Knoll MD; Privor-Dumm L
Vaccine; 2021 Mar; 39(11):1556-1564. PubMed ID: 33618947
[TBL] [Abstract][Full Text] [Related]
6. A global agenda for older adult immunization in the COVID-19 era: A roadmap for action.
Privor-Dumm LA; Poland GA; Barratt J; Durrheim DN; Deloria Knoll M; Vasudevan P; Jit M; Bonvehí PE; Bonanni P;
Vaccine; 2021 Aug; 39(37):5240-5250. PubMed ID: 32703743
[TBL] [Abstract][Full Text] [Related]
7. Using a low-cost, real-time electronic immunization registry in Pakistan to demonstrate utility of data for immunization programs and evidence-based decision making to achieve SDG-3: Insights from analysis of Big Data on vaccines.
Siddiqi DA; Abdullah S; Dharma VK; Shah MT; Akhter MA; Habib A; Khan AJ; Chandir S
Int J Med Inform; 2021 May; 149():104413. PubMed ID: 33652259
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of health economic evaluation into immunization policy-making in Canada: Barriers and facilitators.
Hopman HA; Crowcroft NS; Cesuroglu T; Langley JM
Vaccine; 2020 Mar; 38(11):2512-2518. PubMed ID: 32057578
[TBL] [Abstract][Full Text] [Related]
10. Strengthening global vaccine access for adolescents and adults.
Nanni A; Meredith S; Gati S; Holm K; Harmon T; Ginsberg A
Vaccine; 2017 Dec; 35(49 Pt B):6823-6827. PubMed ID: 29122384
[TBL] [Abstract][Full Text] [Related]
11. New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries.
Burchett HE; Mounier-Jack S; Griffiths UK; Biellik R; Ongolo-Zogo P; Chavez E; Sarma H; Uddin J; Konate M; Kitaw Y; Molla M; Wakasiaka S; Gilson L; Mills A
Health Policy Plan; 2012 May; 27 Suppl 2():ii5-16. PubMed ID: 22513732
[TBL] [Abstract][Full Text] [Related]
12. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017.
Teresa Aguado M; Barratt J; Beard JR; Blomberg BB; Chen WH; Hickling J; Hyde TB; Jit M; Jones R; Poland GA; Friede M; Ortiz JR
Vaccine; 2018 Feb; 36(7):921-931. PubMed ID: 29336923
[TBL] [Abstract][Full Text] [Related]
13. Healthcare workers' perceptions and experiences of communicating with people over 50 years of age about vaccination: a qualitative evidence synthesis.
Glenton C; Carlsen B; Lewin S; Wennekes MD; Winje BA; Eilers R;
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013706. PubMed ID: 34282603
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.
Jauregui B; Garcia AG; Bess Janusz C; Blau J; Munier A; Atherly D; Mvundura M; Hajjeh R; Lopman B; Clark AD; Baxter L; Hutubessy R; de Quadros C; Andrus JK
Vaccine; 2015 May; 33 Suppl 1(0 1):A28-33. PubMed ID: 25919170
[TBL] [Abstract][Full Text] [Related]
15. National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.
Donadel M; Panero MS; Ametewee L; Shefer AM
Vaccine; 2021 Apr; 39(14):1897-1909. PubMed ID: 33750592
[TBL] [Abstract][Full Text] [Related]
16. The CAPACITI Decision-Support Tool for National Immunization Programs.
Botwright S; Giersing BK; Meltzer MI; Kahn AL; Jit M; Baltussen R; El Omeiri N; Biey JN; Moore KL; Thokala P; Mwenda JM; Bertram M; Hutubessy RCW
Value Health; 2021 Aug; 24(8):1150-1157. PubMed ID: 34372981
[TBL] [Abstract][Full Text] [Related]
17. Implementation of maternal influenza immunization in El Salvador: Experiences and lessons learned from a mixed-methods study.
Fleming JA; Baltrons R; Rowley E; Quintanilla I; Crespin E; Ropero AM; Ortiz JR; Lambach P; Neuzil KM; Stepanchak M; Hombach J; Bhat N
Vaccine; 2018 Jun; 36(28):4054-4061. PubMed ID: 29859803
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccine policy development in a sample of 44 countries - Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs).
Kahn AL; Steffen CA; Henaff L; MacDonald NE; Morgan C; Faden R; Olayinka F; Desai S
Vaccine; 2023 Jan; 41(3):676-683. PubMed ID: 36494252
[TBL] [Abstract][Full Text] [Related]
19. Economic and immunisation safety surveillance characteristics of countries implementing no-fault compensation programmes for vaccine injuries.
Mungwira RG; Maure CG; Zuber PLF
Vaccine; 2019 Jul; 37(31):4370-4375. PubMed ID: 31213377
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
